Terms & Conditions
Please read these terms carefully before using Autonomous Biomarker Discovery Engine's AI-powered healthcare platform
Welcome to Autonomous Biomarker Discovery Engine
These Terms and Conditions ("Terms") govern your use of Autonomous Biomarker Discovery Engine's AI-powered biomarker discovery platform. By accessing or using our services, you agree to be bound by these Terms and our Privacy Policy. Our platform is designed specifically for healthcare professionals and research institutions.
By accessing, browsing, or using Autonomous Biomarker Discovery Engine's platform, you acknowledge that you have read, understood, and agree to be bound by these Terms and Conditions, as well as our Privacy Policy and any additional terms that may apply to specific features or services.
These Terms constitute a legally binding agreement between you and Autonomous Biomarker Discovery Engine. If you do not agree with any part of these Terms, you must not use our platform or services.
2.1 Eligibility Requirements
To use Autonomous Biomarker Discovery Engine, you must be:
- A licensed healthcare professional, medical researcher, or authorized representative of a healthcare institution
- At least 18 years of age or the age of majority in your jurisdiction
- Legally authorized to enter into binding agreements
- In compliance with all applicable laws and regulations in your jurisdiction
2.2 Account Registration
You must provide accurate, current, and complete information during registration. You are responsible for maintaining the confidentiality of your account credentials and for all activities under your account.
2.3 Institutional Accounts
For institutional accounts, the registered administrator is responsible for ensuring all users comply with these Terms and applicable healthcare regulations.
3.1 License Grant
Subject to these Terms, we grant you a limited, non-exclusive, non-transferable, revocable license to access and use the Autonomous Biomarker Discovery Engine platform for legitimate healthcare and research purposes.
3.2 Permitted Uses
- Biomarker-based diagnosis and treatment planning
- Medical research and academic studies
- Quality improvement initiatives in healthcare
- Educational purposes within accredited institutions
3.3 Prohibited Uses
You may not:
- Use the platform for non-medical commercial purposes
- Share access credentials with unauthorized persons
- Reverse engineer, decompile, or attempt to extract source code
- Upload malicious code or attempt to compromise system security
- Use the platform in violation of any applicable laws or regulations
4.1 Patient Data Responsibility
You remain the data controller for any patient data uploaded to our platform. You are responsible for obtaining all necessary consents and ensuring compliance with applicable privacy laws.
4.2 De-identification Requirements
All patient data must be properly de-identified before upload, following HIPAA Safe Harbor standards or other applicable de-identification guidelines in your jurisdiction.
4.3 Data Processing
We process your data solely to provide our AI analysis services. We do not use patient data for purposes other than providing the requested analysis and improving our algorithms (with aggregated, non-identifiable data only).
4.4 Data Retention
Processed data is retained according to your account settings and our data retention policy. You may request deletion of your data at any time, subject to legal and regulatory requirements.
5.1 Security Measures
We implement industry-standard security measures including:
- End-to-end encryption for data transmission and storage
- Multi-factor authentication for account access
- Regular security audits and penetration testing
- SOC 2 Type II compliance
5.2 Regulatory Compliance
Our platform is designed to comply with:
- Health Insurance Portability and Accountability Act (HIPAA)
- General Data Protection Regulation (GDPR)
- FDA regulations for medical device software
- State and local healthcare data protection laws
5.3 Business Associate Agreement
For HIPAA-covered entities, we will execute a Business Associate Agreement (BAA) as required by law.
6.1 Platform Ownership
Autonomous Biomarker Discovery Engine and all related intellectual property, including algorithms, software, trademarks, and trade secrets, are owned by TranscriptomeAI or our licensors.
6.2 Your Data Rights
You retain ownership of all data you upload to our platform. You grant us a limited license to process this data solely for providing our services.
6.3 Generated Reports
You own the analysis reports generated from your data. However, the underlying algorithms, methodologies, and software remain our intellectual property.
6.4 Feedback and Improvements
Any feedback or suggestions you provide may be used by us to improve our platform without compensation, provided such use does not include patient-specific information.
7.1 Medical Disclaimer
IMPORTANT: Autonomous Biomarker Discovery Engine provides analytical tools for healthcare professionals. Our platform does not replace clinical judgment and should not be used as the sole basis for medical decisions. Always consult with qualified healthcare professionals for patient care decisions.
7.2 Service Availability
While we strive for 99.9% uptime, we cannot guarantee uninterrupted service availability. We are not liable for temporary service interruptions or their impact on your operations.
7.3 Limitation of Liability
To the maximum extent permitted by law, our liability for any claims related to the platform shall not exceed the amount paid by you for the service in the 12 months preceding the claim.
7.4 Warranty Disclaimer
The platform is provided "as is" without warranties of any kind. We disclaim all express and implied warranties, including merchantability and fitness for a particular purpose.
8.1 Governing Law
These Terms are governed by the laws of the State of California, United States, without regard to conflict of law principles.
8.2 Dispute Resolution
Any disputes arising from these Terms or your use of the platform will be resolved through binding arbitration in accordance with the American Arbitration Association's Commercial Arbitration Rules.
8.3 Changes to Terms
We may update these Terms periodically. Material changes will be communicated via email and platform notifications. Continued use after changes constitutes acceptance of the new Terms.
8.4 Severability
If any provision of these Terms is found unenforceable, the remaining provisions will remain in full force and effect.